Early-life stress exacerbates the effects of WIN55,212-2 and modulates the cannabinoid receptor type 1 expression

Neuropharmacology. 2021 Feb 15:184:108416. doi: 10.1016/j.neuropharm.2020.108416. Epub 2020 Nov 30.

Abstract

Early-life stress induces an abnormal brain development and increases the risk of psychiatric diseases, including depression, anxiety and substance use disorders. We have developed a reliable model for maternal neglect, named maternal separation with early weaning (MSEW) in CD1 mice. In the present study, we evaluated the long-term effects on anxiety-like behaviours, nociception as well as the Iba1-positive microglial cells in this model in comparison to standard nest (SN) mice. Moreover, we investigated whether MSEW alters the cannabinoid agonist WIN55,212-2 effects regarding reward, spatial and emotional memories, tolerance to different cannabinoid responses, and physical dependence. Adult male offspring of MSEW group showed impaired responses on spatial and emotional memories after a repeated WIN55,212-2 treatment. These behavioural impairments were associated with an increase in basolateral amygdala and hippocampal CB1-expressing fibres and higher number of CB1-containing cells in cerebellum. Additionally, MSEW promotes a higher number of Iba1-positive microglial cells in basolateral amygdala and cerebellum. As for the cannabinoid-induced effects, rearing conditions did not influence the rewarding effects of WIN55,212-2 in the conditioned place preference paradigm. However, MSEW mice showed a delay in the development of tolerance to the cannabinoid effects. Moreover, CB1-positive fibres were reduced in limbic areas in MSEW mice after cannabinoid withdrawal precipitated with the CB1 antagonist SR141617A. These findings support that early-life stress promotes behavioural and molecular changes in the sensitivity to cannabinoids, which are mediated by alterations in CB1 signalling in limbic areas and it induces an increased Iba1-microglial marker which could interfere in emotional memories formation.

Keywords: Cannabinoid receptor type 1; Iba1; Maternal separation; Memory; Physical dependence; WIN55,212-2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Avoidance Learning / drug effects
  • Avoidance Learning / physiology
  • Benzoxazines* / administration & dosage
  • Brain* / drug effects
  • Brain* / metabolism
  • Cannabinoid Receptor Agonists* / administration & dosage
  • Cannabinoid Receptor Antagonists / administration & dosage
  • Female
  • Gene Expression
  • Male
  • Maternal Deprivation*
  • Maze Learning / drug effects
  • Maze Learning / physiology
  • Mice
  • Morpholines* / administration & dosage
  • Naphthalenes* / administration & dosage
  • Pain Measurement / drug effects
  • Pain Measurement / methods
  • Pregnancy
  • Receptor, Cannabinoid, CB1* / agonists
  • Receptor, Cannabinoid, CB1* / antagonists & inhibitors
  • Receptor, Cannabinoid, CB1* / biosynthesis
  • Rimonabant / administration & dosage
  • Stress, Psychological

Substances

  • (3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanone
  • Benzoxazines
  • Cannabinoid Receptor Agonists
  • Cannabinoid Receptor Antagonists
  • Morpholines
  • Naphthalenes
  • Receptor, Cannabinoid, CB1
  • Rimonabant